Ignite Creation Date:
2024-05-06 @ 3:21 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02272998
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-18
First Post:
2014-10-21
Brief Title:
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes FGFR1 FGFR2 FGFR3 FGFR4 RET KIT
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center